Free Trial

Calidi Biotherapeutics (CLDI) Insider Trading & Ownership

Calidi Biotherapeutics logo
$0.19 0.00 (-2.26%)
Closing price 05/15/2026 04:10 PM Eastern
Extended Trading
$0.18 -0.01 (-3.02%)
As of 05/15/2026 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Calidi Biotherapeutics (NYSEAMERICAN:CLDI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.30%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$455K
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$1.24K
Get CLDI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Calidi Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CLDI Insider Buying and Selling by Quarter

Calidi Biotherapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/12/2025
Allan Camaisa
Director
Sell850$1.46$1,241.00  
8/21/2025
Andrew C Jackson
CFO
Buy2,500$2.00$5,000.00  
8/21/2025
Eric E Poma
CEO
Buy25,000$2.00$50,000.00  
8/21/2025
James A Schoeneck
Director
Buy75,000$2.00$150,000.00  
8/21/2025
Scott Leftwich
Director
Buy125,000$2.00$250,000.00  
(Data available from 1/1/2013 forward)

CLDI Insider Trading Activity - Frequently Asked Questions

The list of insiders at Calidi Biotherapeutics includes Allan Camaisa, Andrew C Jackson, Eric E Poma, James A Schoeneck, and Scott Leftwich. Learn more on insiders at CLDI.

4.30% of Calidi Biotherapeutics stock is owned by insiders. Learn more on CLDI's insider holdings.

The following insiders have purchased CLDI shares in the last 24 months: Andrew C Jackson ($5,000.00), Eric E Poma ($50,000.00), James A Schoeneck ($150,000.00), and Scott Leftwich ($250,000.00).

Insiders have purchased a total of 227,500 CLDI shares in the last 24 months for a total of $455,000.00 bought.

The following insider sold CLDI shares in the last 24 months: Allan Camaisa ($17,434.52).

Insiders have sold a total of 1,683 Calidi Biotherapeutics shares in the last 24 months for a total of $17,434.52 sold.



This page (NYSEAMERICAN:CLDI) was last updated on 5/16/2026 by MarketBeat.com Staff.
From Our Partners